Scientists Find That Lucid Dreaming Is Actually A New State Of Consciousness
After analyzing many previous studies on lucid dreaming, researchers have defined it as a state that differs significantly from both REM sleep and wakefulness.
The awareness of dreaming during a lucid dream is now thought to come from shifts in brain wave activity undergone by several parts of the brain, including the right central lobe, parietal lobe and precuneus.
Lucid dreams were also found to have effects similar to psychedelics like LSD.
Have you ever had a dream in which you realized you were dreaming?
When you become conscious of the fact that you are dreaming, you can take advantage of that knowledge and manipulate the dream. If you want to do something that is physically impossible in the real world, such as flying, you can leap into the air and take flight. Someone who realizes they are trapped in a nightmare can convince themselves to wake up.
The state known as lucid dreaming is an unquestionably surreal one, and it just got even more so. A team of researchers—led by Çağatay Demirel from the Donders Center for Cognitive Neuroimaging at Radboud University Medical Center, the Netherlands—has discovered that lucid dreaming has now been found to be a state of consciousness separate from both wakefulness and REM sleep (the state usually associated with dreams), and is in fact associated with its own unique type of brain activity. They published a study on their findings in the Journal of Neuroscience.
'This research opens the door to a deeper understanding of lucid dreaming as an intricate state of consciousness by pointing to the possibility that conscious experience can arise from within sleep itself,' Demirel said in a press release.
To identify what sets lucid dreaming apart from the rest of sleep, he and his team pulled previous studies—in which brain activity was measured with EEG sensors—together into what is now the most extensive dataset in this field of sleep research. The researchers then compared brain activity patterns for wakefulness, REM sleep, and lucid dreaming to find that that the eerie self-awareness experienced in lucid dreams has a connection to the electrical rhythms in neurons known as brain waves.
Perception and memory processing in the lucid dreaming state were found to be different from non-lucid REM sleep. The consciousness of existing in a dream was associated with with beta waves in the right temporal lobe (which controls spatial awareness and nonverbal memory) and parietal lobe (which controls the sense of touch and self-perception). Beta waves are a type of high-frequency electromagnetic activity in the brain involved in conscious thought processes like solving problems or making decisions. Our consciousness is dominated by beta waves when we are awake.
This might explain why there is so much cognitive control in lucid dreams. Dreamers deep in REM sleep have no sense of control over factors like thoughts, feelings, and behaviors, but those in lucid dreaming states do.
Demirel also linked gamma waves with lucid dreaming. These are the fastest brain waves, which become visible on an EEG at times when the brain is especially alert and focusing on something. When lucid dreaming begins, gamma waves increase in the right precuneus, which is involved in self-referential thinking—thoughts about ourselves and our lives. When we are awake, we often drift into this type of thinking when our minds wander.
Maybe the most mind-bending thing about lucid dreams is that they are, according to the study, similar in the brain to the effects of psychedelic drugs such as LSD and ayahuasca. These types of psychedelic experiences are also associated with the precuneus, whose activity is modified when waking imagery is seen despite having closed eyes (something usually only experienced with psychedelics). Interestingly, however, lucid dreams may even go a few experiential steps past psychedelics. 'While psychedelics often lead to a dissolution of ego and decreased self-referential processing […] lucid dreams may actually harness elements of self-awareness and control,' Demirel and his team said in the study.
So if you're capable of lucid dreaming, you're in for an awesome trip.
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 days ago
- Yahoo
Scientists Finally Found the Psychedelic Source of LSD
Here's what you'll learn when you read this story: The fungus from which LSD was first synthesized has finally been observed and described by researchers who suspected a fuzz inside the seed coats of morning glory plants. Now known as Periglandula clandestina, this fungal symbiote that coexists with morning glories was so difficult to find because it lives inside the plant as opposed to its Periglandula relatives which live on the outsides of plants and are more easily observable. In the future, P. clandestine could lead to new and more powerful pharmaceuticals that treat migraines and neurodegenerative conditions. In 1963, Swiss chemist Albert Hofmann discovered what gave morning glories psychoactive properties, the lysergic acid amides that would later lead him to (accidentally) create LSD. Hofmann already knew about a mind-altering hallucinogen in morning glories that had been used in Mesoamerican religious rituals since ancient times. Seeing these chemicals in a plant was unexpected, since they are usually associated with fungi. The morning glory fungus eluded him. Finding it would prove to be a trip. Morning glories (Convolvulaceae) are known for having symbiotic relationships with fungi that produce ergot alkaloids. These are the mycotoxins from which some hallucinogens, along with powerful medications for conditions such as dementia and migraines are derived. Many of the fungi that produce these substances belong to the family Clavicipitaceae. While many species of morning glories have been found to contain ergot alkaloids, their fungal symbionts have not always been observed easily. Clavicipitaceae are often detected through DNA or their disappearance when a plant is treated with fungicide. Researchers Corinne Hazel and Daniel Panaccione of West Virginia University knew of evidence for a psychotropic fungus in morning glories. The seed-borne fungus is a Clavicipitaceous genus known as Periglandula, and lives in symbiosis with the morning glory species Ipomoea tricolor, but had never been described further. 'The presence of ergot alkaloids in I. tricolor was associated with [genetic] sequences of an undescribed fungus of the family Clavicipitaceae,' Hazel and Panaccione said in a study recently published in Mycologia. 'Further evidence of a fungal symbiont of I. tricolor included suppression of ergot alkaloid synthesis through treatment with [a] fungicide.' The researchers sought to isolate the fungus and sequence its genome so they could finally describe it. Plant tissues were magnified up to 200 times to search for visible signs of mycelium. Hyphae are the filaments in mycelium which branch out and connect networks of mushrooms underground and make up that dreaded white fuzz seen on moldy bread. Some of morning glory tissues were stained so the mycelium would be easier to identify, and other tissues were given nutrients to promote fungal growth. Because Clavicipitaceae live in seeds, DNA from was also extracted from morning glory seed coats. Hazel knew she was onto something when she spotted white fuzz growing insides of sed coats and suspected fungi. When scientists sequenced the genome of the fungus was sequenced, they found a previously undescribed species of Periglandula. Hazel named it Periglandula clandestina because of how it hides itself within the morning glory plant, which separates it from the other known Periglandula species that grow on the outside of the plant and are not as secretive. Ergot alkaloids were found throughout the plants. They are even present in the roots, where there was no evidence of P. clandestina DNA. The most common alkaloid found in the plants was lysergic acid alpha-hydroxyethylamide (LAH). This alkaloid is one of the lysergic acid amides Hofman identified in his studies. LSD aside, the discovery of the fungus it is synthesized from could open opportunities for significant pharmaceutical discoveries in the future. 'Because P. clandestina produces exceptionally high quantities of ergot alkaloids, the genes in its ergot alkaloid biosynthesis pathway may be a resource for engineering model organisms to overproduce pharmaceutically relevant ergot alkaloids,' said Hazel and Panaccione. The discovery that flowered from a suspicion about fuzz on a seed coat is almost as accidental as the discovery of a substance that will forever be associated with the undulating rainbows of '60s psychedelia, the Beatles' iconic 'Lucy in the Sky With Diamonds,' and even cult pop culture icons like Futurama's Hypnotoad. Even Hoffman himself is quoted as saying, 'I did not choose LSD. LSD found and called me.' You Might Also Like The Do's and Don'ts of Using Painter's Tape The Best Portable BBQ Grills for Cooking Anywhere Can a Smart Watch Prolong Your Life?
Yahoo
4 days ago
- Yahoo
Elusive LSD Fungus Finally Discovered on Flower
An elusive fungus capable of generating quantities of a compound used to synthesize the hallucinogen LSD has finally been discovered on the morning glory vine after decades of searching. Almost a century ago, the Swiss chemist Albert Hoffman hypothesized the whimsical plant might harbor a species that belongs to a family of ergot-generating fungi. As the man who discovered and was first to synthesize LSD ( lysergic acid diethylamide) from the ergot alkaloid, Hoffman had been keen to expand our understanding of the biology and chemistry of organisms that produced it. While biochemical data hinted that a commonly cultivated morning glory from Mexico called Ipomoea tricolor may host just such a fungus, the symbiotic species itself has never been detected. That is, until Corinne Hazel, an environmental microbiologist from West Virginia University, noticed a telltale layer of fuzz on the outer layer of her Ipomoea tricolor seeds. She was investigating the way the plants transmit the evasive fungus's ergot alkaloids through their root systems. This psychedelic byproduct of fungal symbiosis has already been detected in a quarter of the 200 morning glory species sampled from herbarium collections. Biologists had all the evidence they needed to know the fungus was there in this particular plant – except for the fungus itself. "People have been looking for this fungus for years, and one day, I look in the right place, and there it is," Hazel says. "We had a ton of plants lying around and they had these tiny little seed coats. We noticed a little bit of fuzz in the seed coat. That was our fungus." After microscope and genetic analysis, Hazel and her collaborator, botanist Daniel Panaccione, concluded the fungus was new to science, and have named it Periglandula clandestina. With biochemical analysis of the fungus suggesting it's capable of producing high amounts of the alkaloid, genetic studies might yet reveal insights into its evolution and even ways to steal its secrets for the production of pharmaceuticals. "Morning glories contain high concentrations of similar lysergic acid derivatives that give them their psychedelic activities," Panaccione says. "Many things are toxic. But if you administer them in the right dosage or modify them, they can be useful pharmaceuticals. By studying them, we may be able to figure out ways to bypass the side effects. These are big issues for medicine and agriculture." The research is published in Mycologia. We've Finally Seen The Skyscraper Tsunami That Shook Earth For 9 Days Astronauts Reveal The Shocking Beauty of Lightning From Space Sloths The Size of Elephants Roamed America, Before Abruptly Vanishing
Business Insider
4 days ago
- Business Insider
Google's AI CEO explains why he's not interested in taking LSD in his quest to understand 'the nature of reality'
The Google DeepMind CEO said he's never taken LSD and doesn't want to. In a recent interview with Wired's Steven Levy, the AI boss was asked about his pursuit of understanding the "nature of reality," as his X bio states. More specifically, Hassabis was asked if acid had ever helped him get a glimpse of the nature of reality. The short answer is no. "I didn't do it like that," Hassabis said. "I just did it through my gaming and reading a hell of a lot when I was a kid, both science fiction and science." Hassabis set out as a child to understand the universe better, and the quest is ongoing. He's hoping AI and, eventually, artificial general intelligence will help reach his goal. While some tech leaders have talked about using psychedelics, Hassabis said he's "too worried about the effects on the brain." "I've sort of finely tuned my mind to work in this way," he said. "I need it for where I'm going." Google DeepMind is the research lab behind the company's AI projects, including chatbot Gemini. Hassabis is leading Google's charge toward the AI race's holy grail — AGI. Google DeepMind didn't immediately respond to a request for comment from Business Insider. Over the years, Silicon Valley has embraced the use of psychedelics, such as microdosing to improve productivity or going on ayahuasca retreats. Some investors have banked on their popularity, backing psychedelic startups that are seeking to turn the drugs into medical treatments or expand the industry in other ways. However, that's not a green light to take acid or magic mushrooms on the clock. In 2021, CEO Justin Zhu, cofounder and CEO of a startup called Iterable, said he was fired for microdosing LSD before a meeting. He hoped it would improve his focus, he said. Some of Hassabis's tech peers have been open about using LSD as established bosses or as college students. Microsoft cofounder Bill Gates, for example, took acid for the first time as a teenager, according to his memoir, " Source Code: My Beginnings." For Gates, dropping acid was exhilarating at first and a "cosmic" experience when he did it again. However, he ended up thinking his brain could delete his memories like a computer. "That would be one of the last times I would do LSD," Gates said. It didn't have that effect on Apple cofounder Steve Jobs, who told his biographer, Walter Isaacson, that it was "a profound experience, one of the most important things in my life." OpenAI's Sam Altman has also spoken positively about his experience with psychedelics. Although he didn't specify exactly what drug he took, he said it changed him from a "very anxious, unhappy person" to "calm." "If you had told me that, like, one weekend-long retreat in Mexico was going to significantly change that, I would have said absolutely not," Altman said. "And it really did."
